Investors Capital Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CS
O
Investors Capital Advisory Services's XBI Position: Q1 2016 in Review
Investors Capital Advisory Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2016, closing a stake of 6,793 shares — an estimated $476K sold.
Investors Capital Advisory Services first reported a position in XBI in Q1 2015 and held it in 4 quarters. The position peaked at $476K in Q4 2015. 195 funds tracked by Wall St. Rank hold XBI as of Q1 2016.
- Investors Capital Advisory Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2016 after selling out during the quarter.
- Investors Capital Advisory Services sold 6,793 State Street SPDR S&P Biotech ETF shares in Q1 2016, an estimated $476K.
- Investors Capital Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and held it in 4 quarters.
- Investors Capital Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $476K in Q4 2015.
- 195 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2016.
Based on Investors Capital Advisory Services's 13F filing for Q1 2016, filed 9 May 2016.